Evidence map›Paper›PMID 24046146›Full record

ReviewCurrent diabetes reports2013

Technology to optimize pediatric diabetes management and outcomes.

Jessica T Markowitz, Kara R Harrington, Lori M B Laffel

Abstract readReview
In one paragraph

Review in Current diabetes reports, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Text messaging intervention for teens and young adults with diabetes.Journal of diabetes science and technology · 2014
    Trial
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Impact of new technologies on diabetes care.World journal of diabetes · 2015
    Article
  17. Article
  18. Article
  19. Article
  20. Medical apps in endocrine diseases - hide and seek.Therapeutic advances in endocrinology and metabolism · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jessica T MarkowitzJoslin Diabetes Center, Pediatric, Adolescent, & Young Adult Section, Boston, MA, 02215, USA, jessica.markowitz@joslin.harvard.edu.
Kara R Harrington
Lori M B Laffel

Funding

Optimizing CGM Use and Metabolic Outcomes in Youth with Type 1 DiabetesR01DK089349 · NIDDK · JOSLIN DIABETES CENTER · PI LAFFEL, LORI M · 2010 to 2013
$2.8M
Optimizing Self-Management Adherence and Glycemic Control in Older Teens with T1DR01DK095273 · NIDDK · JOSLIN DIABETES CENTER · PI ANDERSON, BARBARA JANE, LAFFEL, LORI M · 2012 to 2015
$2.7M
Transitions in care: examining the process for youth with type 1 diabetesK23DK092335 · NIDDK · JOSLIN DIABETES CENTER · PI MARKOWITZ, JESSICA TUTTMAN · 2012 to 2014
$392k
NIDDK NIH HHS 1K23DK092335NIDDK NIH HHS 1R01DK095273NIDDK NIH HHS 5R01DK089349NIDDK NIH HHS K23 DK092335NIDDK NIH HHS R01 DK089349NIDDK NIH HHS R01 DK095273
6 · The paper itself

Abstract

Technology for diabetes management is rapidly developing and changing. With each new development, there are numerous factors to consider, including medical benefits, impact on quality of life, ease of use, and barriers to use. It is also important to consider the interaction between developmental stage and technology. This review considers a number of newer diabetes-related technologies and explores issues related to their use in the pediatric diabetes population (including young adults), with a focus on psychosocial factors. Areas include trend technology in blood glucose monitoring, continuous glucose monitoring, sensor-augmented insulin pumps and low glucose suspend functions, internet applications including videoconferencing, mobile applications (apps), text messaging, and online gaming.

Indexed as

AdolescentBlood GlucoseBlood Glucose Self-MonitoringChildHumansInsulin Infusion SystemsInternetBlood Glucose

Identifiers

PMID24046146
PMCPMC3826790

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.